HOW DIGITAL PATHOLOGY IS REVOLUTIONIZING CLINICAL TRIALS


Authored by Dr. Robert Carlson,VP, Medical Affairs, ACM Global Laboratories

The emergence of digital pathology presents an opportunity for central laboratories to support highly targeted therapeutics and precision medicine even further, offering many advantages to both diagnostic and clinical trials testing. This paper explains the noteworthy progress in the industry’s wider acceptance of digital pathology systems and its many benefits. 


To view the full report, please download your copy.


Clinical Insight Sign-up


Clinical Insight, a series of technical reports, is written by our team of global central lab experts on issues affecting clinical testing today. They provide detailed information concerning current methodology, specimen requirements, and reference ranges on new and specialized tests.

In Clinical Insight, our experts provide their opinions on the clinical significance of specific tests and how they can impact your clinical trial.

Name:
Organization:
Email:
 
 

RECENT CLINICAL INSIGHTS


Allergen Testing in Clinical Trials 
Broadening Pathology Beyond Disease Diagnosis and Classification
The Role of the Central Microbiology Lab in Streamlining Clinical Development
Setting the Standard for Central Labs in Asia Pacific and China
Increasing Standardization and Stability of Multicolor Flow Cytometry Using Duraclone Dry Reagent Technology
Playing a Central Role in Treating Metabolic Syndrome

 
email us: info@acmgloballab.com | follow us:
Consultative Approach Smarter Testing Central Lab Services Global Capabilities Quality Assurance Company Credentials News & Events Contact Us Blog